Evolution of Disease-modifying Therapy for Transthyretin Cardiac Amyloidosis [0.03%]
转甲状腺素蛋白心肌淀粉样变性疾病修正疗法的演变
Adam Ioannou
Adam Ioannou
Transthyretin cardiac amyloidosis (ATTR-CA) represents an inexorably progressive and fatal cardiomyopathy. Increased understanding of the underlying pathogenesis responsible for the misfolding of transthyretin and the subsequent accumulatio...
Femoral Neck Osteoporosis Is Associated with a Higher Odds of Coronary Artery Disease in Indian Postmenopausal Women: A Cross-sectional Study from a Teaching Hospital in Southern India [0.03%]
印度南部教学医院绝经后妇女股骨颈骨质疏松与冠状动脉疾病横断面研究：病例对照研究
Aditya John Binu,Abhishek Mittal,Kripa Elizabeth Cherian et al.
Aditya John Binu et al.
Purpose: Epidemiological studies have shown an association between coronary artery disease (CAD) and osteoporosis. We studied the prevalence of CAD among postmenopausal women with osteoporosis. Factors that were significantly associated wit...
A Comprehensive Evaluation of the NAVITOR Transcatheter Aortic Valve Replacement System [0.03%]
NAVITOR经导管主动脉瓣膜系统综合评估
Joe Aoun,Syed Zaid,Sachin Goel et al.
Joe Aoun et al.
Transcatheter aortic valve replacement (TAVR) has undergone significant advancements in the last two decades, expanding its indications and refining transcatheter heart valve (THV) and delivery system designs to improve procedural success a...
A Personalized Approach to the Management of Congestion in Acute Heart Failure [0.03%]
急性心力衰竭时 congestion管理的个体化方法
Gustavo R Moreira,Humberto Villacorta
Gustavo R Moreira
Heart failure (HF) is the common final pathway of several conditions and is characterized by hyperactivation of numerous neurohumoral pathways. Cardiorenal interaction plays an essential role in the progression of the disease, and the use o...
Michael Albosta,Jelani K Grant,Erin D Michos
Michael Albosta
The management of low-density lipoprotein cholesterol (LDL-C) levels is a central strategy for the prevention of atherosclerotic cardiovascular disease. Current United States (2018 American Heart Association/American College of Cardiology/M...
Sarcopenic Obesity as a Risk Factor for Cardiovascular Disease: An Underrecognized Clinical Entity [0.03%]
肌少型肥胖作为心血管疾病的风险因素：一个被忽视的临床实体
Aditya John Binu,Nitin Kapoor,Saptarshi Bhattacharya et al.
Aditya John Binu et al.
Sarcopenic obesity (SO) is a chronic condition and an emerging health challenge, in view of the growing elderly population and the obesity epidemic. Due to a lack of awareness among treating doctors and the non-specific nauture of the assoc...
Assessment and Management of Ischaemic Heart Disease in Non-Cardiac Surgery [0.03%]
非心脏手术中缺血性心脏病的评估与管理
Holly Morgan,Saad M Ezad,Haseeb Rahman et al.
Holly Morgan et al.
In the setting of non-cardiac surgery, cardiac complications contribute to over a third of perioperative deaths. With over 230 million major surgeries performed annually, and an increasing prevalence of cardiovascular risk factors and ischa...
Conduction System Pacing: Have We Finally Found the Holy Grail of Physiological Pacing? [0.03%]
传导系统起搏：我们是否终于找到了生理起搏的圣杯？
Myriam Kaddour,Haran Burri
Myriam Kaddour
The late fifties are considered a high point in the history of cardiac pacing, since this era is marked by the first pacemaker implantation, which has since evolved into life-saving therapy. Right ventricular apical and biventricular pacing...
Sodium Glucose Co-Transporter 2 Inhibitors and the Cardiovascular System: Current Knowledge and Future Expectations [0.03%]
钠-葡萄糖协同转运蛋白2抑制剂与心血管系统：目前的认识和未来的期望
Ioannis Boutsikos,Eleftherios Beltsios,Bastian Schmack et al.
Ioannis Boutsikos et al.
Diabetic cardiomyopathy is a well-recognized clinical entity and reflects a complex relationship between metabolic substrates and myocardial function. Sodium glucose co-transporter 2 (SGLT2) inhibitors are antidiabetic agents that are found...
Balloon Aortic Valvuloplasty in the Transcatheter Aortic Valve Implantation Era [0.03%]
经导管主动脉瓣植入术时代的球囊主动脉瓣成形术
Gustavo Arturo Samaja
Gustavo Arturo Samaja
As the population continues to grow, and life expectancy has increased, aortic stenosis (AS) has become the most common valvular disease requiring surgical treatment. The evolution of valve replacement therapies has progressed significantly...